col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: IMA Press, LLC

43 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Neurology neuropsychiatry Psychosomatics 2022―Aug―05 Review of human interferons and the potential of their use in the complex therapy of a new coronavirus infection COVID-19 E. V. Granatov, A. R. Abashev, F. A. Khabirov, A. Ya. Dykhanov, T. I. Khaibullin
2 [GO] Neurology neuropsychiatry Psychosomatics 2022―Aug―05 Autoimmune spinal cord lesions associated with novel coronavirus infection A. O. Kozlova, D. D. Eliseeva, T. O. Simaniv, V. V. Bryukhov, E. V. Baidina, M. N. Zakharova
3 [GO] Neurology neuropsychiatry Psychosomatics 2022―Jun―21 Acute and long-term neurological disorders in patients with coronavirus infection V. A. Parfenov, A. A. Kulesh
4 [GO] Modern Rheumatology Journal 2022―May―08 Analysis of the mechanisms of development of neurorheumatological consequences of COVID-19 and the possibility of their pharmacological correction I. V. Sarvilina, A. M. Lila, O. A. Gromova, I. Yu. Torshin, O. A. Shavlovskaya, E. A. Taskina
5 [GO] Modern Rheumatology Journal 2022―May―08 Use of telemedicine consultations in rheumatology during the COVID-19 pandemic O. V. Teplyakova, A. A. Morozova
6 [GO] Modern Rheumatology Journal 2022―May―08 Organ changes after SARS-CoV-2 infection in a patient with systemic sclerosis according to autopsy O. V. Vorobeva, L. P. Romanova
7 [GO] Neurology neuropsychiatry Psychosomatics 2022―Feb―27 COVID-19 associated multiple cranial neuropathies M. Yu. Maksimova, Ya. O. Grusha, E. I. Fettser
8 [GO] Neurology neuropsychiatry Psychosomatics 2022―Feb―27 Validation of the Russian version of Stress and Anxiety to Viral Epidemics - 9 items (SAVE-9) among healthcare workers during COVID-19 pandemic E. S. Mosolova, S. Chung, D. N. Sosin, S. N. Mosolov
9 [GO] Modern Rheumatology Journal 2022―Feb―20 Important aspects of osteoarthritis therapy during the COVID-19 pandemic A. M. Lila, A. G. Chuchalin, I. Yu. Torshin, O. A. Gromova
10 [GO] Modern Rheumatology Journal 2022―Feb―20 Safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic diseases (preliminary data) A. N. Kulikov, N. V. Muravyeva, B. S. Belov
11 [GO] Modern Rheumatology Journal 2022―Feb―20 COVID-19-associated angiitis: literature review and case report D. I. Abdulganieva, N. G. Shamsutdinova, A. A. Gaibaryan
12 [GO] Neurology neuropsychiatry Psychosomatics 2021―Dec―16 Causes and predictors of mental disorders during the COVID-19 pandemic N. A. Tyuvina, V. O. Vysokova, T. N. Maksimova, S. V. Prokhorova
13 [GO] Neurology neuropsychiatry Psychosomatics 2021―Dec―16 Multifactorial model of willingness to get vaccinated in medical students during 3rd wave of COVID-19 pandemic V. L. Malygin, Ya. V. Malygin, A. S. Iskandirova, E. E. Pahtusova, Yu. A. Merkuryeva, V. V. Ogarev, et al. (+2)
14 [GO] Neurology neuropsychiatry Psychosomatics 2021―Dec―16 Possibilities of using amantadines in the setting of the novel coronavirus infection in patients with Parkinson's disease E. A. Katunina, Yu. N. Bezdolnyi, N. N. Shipilova
15 [GO] Modern Rheumatology Journal 2021―Oct―20 Polyarthritis associated with COVID-19 (clinical case) E. S. Aronova, B. S. Belov
16 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Management of patients with pain syndromes associated with COVID-19 L. T. Akhmedzhanova, T. M. Ostroumova, O. A. Solokha
17 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Anticoagulant therapy for stroke prevention in patients with severe COVID-19 A. T. Azimov, G. S. Rakhimbaeva, F. Z. Azimov
18 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration I. V. Sarvilina, O. A. Gromova, A. V. Naumov
19 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Impact of mental disorders on COVID-19 outcomes N. N. Petrova, V. E. Pashkovskiy, M. S. Sivashova, A. N. Gvozdetsky, G. A. Prokopovich
20 [GO] Neurology neuropsychiatry Psychosomatics 2021―Oct―18 Obsessive-compulsive disorder during the SARS-CoV-2 pandemic (case report) N. A. Tiuvina, T. N. Maksimova, S. V. Prokhorova, V. O. Vysokova
21 [GO] Neurology neuropsychiatry Psychosomatics 2021―Sep―16 Acute inflammatory demyelinating pseudotumor after COVID-19 T. I. Yakushina, D. M. Yakushin, I. O. Shtang
22 [GO] Neurology neuropsychiatry Psychosomatics 2021―Sep―16 Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov
23 [GO] Modern Rheumatology Journal 2021―Aug―16 Septal panniculitis as manifestation of COVID-19: own data O. N. Egorova, R. G. Goloeva, D. I. Abdulganieva
24 [GO] Neurology neuropsychiatry Psychosomatics 2021―Jun―24 COVID-19 and epilepsy: Russian and international experience G. V. Odintsova
25 [GO] Neurology neuropsychiatry Psychosomatics 2021―Jun―24 Management tactics in patients with chronic cerebral ischemia during COVID-19 pandemic A. A. Kulesh
26 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) V. A. Kutashov
27 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 COVID-19 vaccination guidelines for patients with multiple sclerosis N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, et al. (+4)
28 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions V. A. Golovacheva, G. R. Tabeeva, I. V. Kuznetsov
29 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Anxiety and depression in COVID-19: treatment options V. E. Medvedev
30 [GO] Neurology neuropsychiatry Psychosomatics 2021―Apr―25 Central pontine myelinolysis in the presence of SARS-CoV-2 infection (clinical observations) O. N. Voskresenskaya, A. A. Kovalenko, E. B. Nadbitova, V. V. Grinyuk, A. V. Klimanov, Yu. M. Shor
31 [GO] Modern Rheumatology Journal 2021―Apr―24 The Prospects of tumor necrosis factor α inhibitors use in patients with COVID-19 E. S. Aronova, B. S. Belov
32 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ V. V. Kovalchuk
33 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic A. G. Merkin, S. S. Akinfieva, A. V. Martyushev-Poklad, O. P. Beloskurskaya, E. N. Dinov, S. L. Ostrovsky, et al. (+5)
34 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Depression during the COVID-19 pandemic (analysis of clinical cases) I. Yu. Dorozhenok
35 [GO] Neurology neuropsychiatry Psychosomatics 2021―Feb―18 Cognitive impairment in COVID-19 survivors T. M. Ostroumova, P. A. Chernousov, I. V. Kuznetsov
36 [GO] Neurology neuropsychiatry Psychosomatics 2020―Dec―13 COVID-19 and mental health: challenges and first conclusions V. E. Medvedev, O. A. Dogotar
37 [GO] Neurology neuropsychiatry Psychosomatics 2020―Dec―13 Somatization disorders of affective and neurotic registers during the COVID-19 pandemic (analysis of clinical cases) I. Yu. Dorozhenok
38 [GO] Neurology neuropsychiatry Psychosomatics 2020―Aug―05 Nervous system damage in COVID-19 with an emphasis on the management of patients with multiple sclerosis A. N. Boyko, S. A. Sivertseva, N. N. Spirin
39 [GO] Neurology neuropsychiatry Psychosomatics 2020―Jun―26 The first experience with Angiovit in the combination treatment of acute COVID-19 infection A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, et al. (+2)
40 [GO] Rheumatology Science and Practice 2020―Jun―24 DO NSAIDS CAUSE SPECIFIC COMPLICATIONS IN COVID-19 CORONAVIRUS INFECTION? A. E. Karateev, E. L. Nasonov, A. M. Lila
41 [GO] Rheumatology Science and Practice 2020―Jun―24 IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6 E. L. Nasonov
42 [GO] Modern Rheumatology Journal 2020―May―31 COVID-19: the new challenge for rheumatologists B. S. Belov, A. E. Karateev
43 [GO] Rheumatology Science and Practice 2020―Apr―27 CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS E. L. Nasonov
 [1] 

43 Results       Page 1




[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.008 sec